nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—CYP3A4—Rivastigmine—Alzheimer's disease	0.103	0.432	CbGbCtD
Fentanyl—CYP3A4—Donepezil—Alzheimer's disease	0.082	0.345	CbGbCtD
Fentanyl—CYP3A4—Galantamine—Alzheimer's disease	0.0528	0.223	CbGbCtD
Fentanyl—OPRM1—telencephalic ventricle—Alzheimer's disease	0.00999	0.203	CbGeAlD
Fentanyl—OPRD1—forebrain—Alzheimer's disease	0.00382	0.0778	CbGeAlD
Fentanyl—OPRK1—forebrain—Alzheimer's disease	0.00367	0.0746	CbGeAlD
Fentanyl—OPRD1—telencephalon—Alzheimer's disease	0.00352	0.0715	CbGeAlD
Fentanyl—OPRM1—forebrain—Alzheimer's disease	0.00261	0.053	CbGeAlD
Fentanyl—OPRM1—telencephalon—Alzheimer's disease	0.0024	0.0488	CbGeAlD
Fentanyl—OPRD1—nervous system—Alzheimer's disease	0.00208	0.0422	CbGeAlD
Fentanyl—OPRD1—central nervous system—Alzheimer's disease	0.002	0.0406	CbGeAlD
Fentanyl—OPRK1—nervous system—Alzheimer's disease	0.00199	0.0405	CbGeAlD
Fentanyl—OPRK1—central nervous system—Alzheimer's disease	0.00192	0.039	CbGeAlD
Fentanyl—OPRK1—cerebellum—Alzheimer's disease	0.00187	0.0381	CbGeAlD
Fentanyl—OPRD1—brain—Alzheimer's disease	0.00159	0.0323	CbGeAlD
Fentanyl—OPRK1—brain—Alzheimer's disease	0.00152	0.0309	CbGeAlD
Fentanyl—ABCB1—blood vessel—Alzheimer's disease	0.00143	0.029	CbGeAlD
Fentanyl—OPRM1—nervous system—Alzheimer's disease	0.00142	0.0288	CbGeAlD
Fentanyl—Aprindine—CALM1—Alzheimer's disease	0.00139	0.123	CrCbGaD
Fentanyl—OPRM1—central nervous system—Alzheimer's disease	0.00136	0.0277	CbGeAlD
Fentanyl—Ifenprodil—GRIN2B—Alzheimer's disease	0.00132	0.116	CrCbGaD
Fentanyl—OPRM1—brain—Alzheimer's disease	0.00108	0.022	CbGeAlD
Fentanyl—Bepridil—CALM1—Alzheimer's disease	0.000859	0.0758	CrCbGaD
Fentanyl—ABCB1—embryo—Alzheimer's disease	0.000851	0.0173	CbGeAlD
Fentanyl—Benazepril—MTHFR—Alzheimer's disease	0.000773	0.0682	CrCbGaD
Fentanyl—Loperamide—CALM1—Alzheimer's disease	0.000761	0.0671	CrCbGaD
Fentanyl—ABCB1—forebrain—Alzheimer's disease	0.000752	0.0153	CbGeAlD
Fentanyl—Trimethaphan—BCHE—Alzheimer's disease	0.000749	0.0661	CrCbGaD
Fentanyl—Quinapril—ACE—Alzheimer's disease	0.000725	0.0639	CrCbGaD
Fentanyl—ABCB1—telencephalon—Alzheimer's disease	0.000692	0.0141	CbGeAlD
Fentanyl—Phenoxybenzamine—CALM1—Alzheimer's disease	0.000669	0.059	CrCbGaD
Fentanyl—Benazepril—ACE—Alzheimer's disease	0.00063	0.0556	CrCbGaD
Fentanyl—CYP3A4—nervous system—Alzheimer's disease	0.000577	0.0117	CbGeAlD
Fentanyl—CYP3A4—central nervous system—Alzheimer's disease	0.000555	0.0113	CbGeAlD
Fentanyl—ABCB1—nervous system—Alzheimer's disease	0.000408	0.0083	CbGeAlD
Fentanyl—Astemizole—CYP2D6—Alzheimer's disease	0.000407	0.0359	CrCbGaD
Fentanyl—ABCB1—central nervous system—Alzheimer's disease	0.000393	0.00799	CbGeAlD
Fentanyl—ABCB1—cerebellum—Alzheimer's disease	0.000384	0.00781	CbGeAlD
Fentanyl—Urethral disorder—Memantine—Alzheimer's disease	0.000384	0.000616	CcSEcCtD
Fentanyl—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000383	0.000615	CcSEcCtD
Fentanyl—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000382	0.000613	CcSEcCtD
Fentanyl—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000381	0.000612	CcSEcCtD
Fentanyl—Hallucination—Rivastigmine—Alzheimer's disease	0.000381	0.000612	CcSEcCtD
Fentanyl—Alopecia—Donepezil—Alzheimer's disease	0.000381	0.000612	CcSEcCtD
Fentanyl—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00038	0.00061	CcSEcCtD
Fentanyl—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000379	0.000607	CcSEcCtD
Fentanyl—Mental disorder—Donepezil—Alzheimer's disease	0.000378	0.000606	CcSEcCtD
Fentanyl—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000378	0.000606	CcSEcCtD
Fentanyl—Visual impairment—Memantine—Alzheimer's disease	0.000378	0.000606	CcSEcCtD
Fentanyl—Anorexia—Galantamine—Alzheimer's disease	0.000377	0.000605	CcSEcCtD
Fentanyl—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000377	0.000604	CcSEcCtD
Fentanyl—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000376	0.000603	CcSEcCtD
Fentanyl—Erythema—Donepezil—Alzheimer's disease	0.000376	0.000602	CcSEcCtD
Fentanyl—Malnutrition—Donepezil—Alzheimer's disease	0.000376	0.000602	CcSEcCtD
Fentanyl—Erythema multiforme—Memantine—Alzheimer's disease	0.00037	0.000594	CcSEcCtD
Fentanyl—Flatulence—Donepezil—Alzheimer's disease	0.00037	0.000594	CcSEcCtD
Fentanyl—Hypotension—Galantamine—Alzheimer's disease	0.00037	0.000593	CcSEcCtD
Fentanyl—Visual impairment—Rivastigmine—Alzheimer's disease	0.000369	0.000592	CcSEcCtD
Fentanyl—Tension—Donepezil—Alzheimer's disease	0.000369	0.000591	CcSEcCtD
Fentanyl—Dysgeusia—Donepezil—Alzheimer's disease	0.000368	0.00059	CcSEcCtD
Fentanyl—Phenylbutazone—PTGS1—Alzheimer's disease	0.000368	0.0324	CrCbGaD
Fentanyl—Eye disorder—Memantine—Alzheimer's disease	0.000366	0.000587	CcSEcCtD
Fentanyl—Tinnitus—Memantine—Alzheimer's disease	0.000365	0.000586	CcSEcCtD
Fentanyl—Nervousness—Donepezil—Alzheimer's disease	0.000365	0.000585	CcSEcCtD
Fentanyl—Flushing—Memantine—Alzheimer's disease	0.000364	0.000583	CcSEcCtD
Fentanyl—Cardiac disorder—Memantine—Alzheimer's disease	0.000364	0.000583	CcSEcCtD
Fentanyl—Back pain—Donepezil—Alzheimer's disease	0.000363	0.000583	CcSEcCtD
Fentanyl—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000362	0.000581	CcSEcCtD
Fentanyl—Muscle spasms—Donepezil—Alzheimer's disease	0.000361	0.000579	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00036	0.000578	CcSEcCtD
Fentanyl—Eye disorder—Rivastigmine—Alzheimer's disease	0.000358	0.000574	CcSEcCtD
Fentanyl—Insomnia—Galantamine—Alzheimer's disease	0.000358	0.000574	CcSEcCtD
Fentanyl—Tinnitus—Rivastigmine—Alzheimer's disease	0.000357	0.000573	CcSEcCtD
Fentanyl—Flushing—Rivastigmine—Alzheimer's disease	0.000356	0.00057	CcSEcCtD
Fentanyl—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000356	0.00057	CcSEcCtD
Fentanyl—Angiopathy—Memantine—Alzheimer's disease	0.000355	0.00057	CcSEcCtD
Fentanyl—Paraesthesia—Galantamine—Alzheimer's disease	0.000355	0.00057	CcSEcCtD
Fentanyl—Vision blurred—Donepezil—Alzheimer's disease	0.000354	0.000568	CcSEcCtD
Fentanyl—Immune system disorder—Memantine—Alzheimer's disease	0.000354	0.000568	CcSEcCtD
Fentanyl—Mediastinal disorder—Memantine—Alzheimer's disease	0.000353	0.000566	CcSEcCtD
Fentanyl—Tremor—Donepezil—Alzheimer's disease	0.000352	0.000564	CcSEcCtD
Fentanyl—Somnolence—Galantamine—Alzheimer's disease	0.000352	0.000564	CcSEcCtD
Fentanyl—Chills—Memantine—Alzheimer's disease	0.000352	0.000564	CcSEcCtD
Fentanyl—Arrhythmia—Memantine—Alzheimer's disease	0.00035	0.000561	CcSEcCtD
Fentanyl—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000349	0.000559	CcSEcCtD
Fentanyl—Dyspepsia—Galantamine—Alzheimer's disease	0.000348	0.000558	CcSEcCtD
Fentanyl—Angiopathy—Rivastigmine—Alzheimer's disease	0.000348	0.000558	CcSEcCtD
Fentanyl—Anaemia—Donepezil—Alzheimer's disease	0.000347	0.000557	CcSEcCtD
Fentanyl—Alopecia—Memantine—Alzheimer's disease	0.000346	0.000555	CcSEcCtD
Fentanyl—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000345	0.000554	CcSEcCtD
Fentanyl—Agitation—Donepezil—Alzheimer's disease	0.000345	0.000554	CcSEcCtD
Fentanyl—Chills—Rivastigmine—Alzheimer's disease	0.000344	0.000552	CcSEcCtD
Fentanyl—Decreased appetite—Galantamine—Alzheimer's disease	0.000344	0.000551	CcSEcCtD
Fentanyl—Mental disorder—Memantine—Alzheimer's disease	0.000343	0.00055	CcSEcCtD
Fentanyl—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000342	0.000549	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000342	0.000548	CcSEcCtD
Fentanyl—Malnutrition—Memantine—Alzheimer's disease	0.000341	0.000547	CcSEcCtD
Fentanyl—Fatigue—Galantamine—Alzheimer's disease	0.000341	0.000547	CcSEcCtD
Fentanyl—Malaise—Donepezil—Alzheimer's disease	0.000339	0.000543	CcSEcCtD
Fentanyl—Alopecia—Rivastigmine—Alzheimer's disease	0.000339	0.000543	CcSEcCtD
Fentanyl—Constipation—Galantamine—Alzheimer's disease	0.000338	0.000542	CcSEcCtD
Fentanyl—Vertigo—Donepezil—Alzheimer's disease	0.000338	0.000541	CcSEcCtD
Fentanyl—Aprindine—CYP2D6—Alzheimer's disease	0.000337	0.0298	CrCbGaD
Fentanyl—Syncope—Donepezil—Alzheimer's disease	0.000337	0.00054	CcSEcCtD
Fentanyl—Flatulence—Memantine—Alzheimer's disease	0.000336	0.000539	CcSEcCtD
Fentanyl—Mental disorder—Rivastigmine—Alzheimer's disease	0.000336	0.000539	CcSEcCtD
Fentanyl—Tension—Memantine—Alzheimer's disease	0.000335	0.000537	CcSEcCtD
Fentanyl—Dysgeusia—Memantine—Alzheimer's disease	0.000334	0.000536	CcSEcCtD
Fentanyl—Malnutrition—Rivastigmine—Alzheimer's disease	0.000334	0.000535	CcSEcCtD
Fentanyl—Erythema—Rivastigmine—Alzheimer's disease	0.000334	0.000535	CcSEcCtD
Fentanyl—Nervousness—Memantine—Alzheimer's disease	0.000331	0.000531	CcSEcCtD
Fentanyl—Loss of consciousness—Donepezil—Alzheimer's disease	0.00033	0.000529	CcSEcCtD
Fentanyl—Back pain—Memantine—Alzheimer's disease	0.00033	0.000529	CcSEcCtD
Fentanyl—Flatulence—Rivastigmine—Alzheimer's disease	0.000329	0.000527	CcSEcCtD
Fentanyl—Cough—Donepezil—Alzheimer's disease	0.000328	0.000526	CcSEcCtD
Fentanyl—Tension—Rivastigmine—Alzheimer's disease	0.000327	0.000525	CcSEcCtD
Fentanyl—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000327	0.000524	CcSEcCtD
Fentanyl—Feeling abnormal—Galantamine—Alzheimer's disease	0.000326	0.000523	CcSEcCtD
Fentanyl—Convulsion—Donepezil—Alzheimer's disease	0.000325	0.000522	CcSEcCtD
Fentanyl—Hypertension—Donepezil—Alzheimer's disease	0.000324	0.00052	CcSEcCtD
Fentanyl—Nervousness—Rivastigmine—Alzheimer's disease	0.000324	0.00052	CcSEcCtD
Fentanyl—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000323	0.000519	CcSEcCtD
Fentanyl—Back pain—Rivastigmine—Alzheimer's disease	0.000323	0.000518	CcSEcCtD
Fentanyl—Vision blurred—Memantine—Alzheimer's disease	0.000321	0.000515	CcSEcCtD
Fentanyl—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000321	0.000514	CcSEcCtD
Fentanyl—Myalgia—Donepezil—Alzheimer's disease	0.00032	0.000513	CcSEcCtD
Fentanyl—Chest pain—Donepezil—Alzheimer's disease	0.00032	0.000513	CcSEcCtD
Fentanyl—Arthralgia—Donepezil—Alzheimer's disease	0.00032	0.000513	CcSEcCtD
Fentanyl—Tremor—Memantine—Alzheimer's disease	0.00032	0.000512	CcSEcCtD
Fentanyl—Anxiety—Donepezil—Alzheimer's disease	0.000319	0.000511	CcSEcCtD
Fentanyl—Ill-defined disorder—Memantine—Alzheimer's disease	0.000316	0.000507	CcSEcCtD
Fentanyl—Discomfort—Donepezil—Alzheimer's disease	0.000316	0.000507	CcSEcCtD
Fentanyl—Anaemia—Memantine—Alzheimer's disease	0.000315	0.000506	CcSEcCtD
Fentanyl—Vision blurred—Rivastigmine—Alzheimer's disease	0.000314	0.000504	CcSEcCtD
Fentanyl—Agitation—Memantine—Alzheimer's disease	0.000313	0.000503	CcSEcCtD
Fentanyl—Dry mouth—Donepezil—Alzheimer's disease	0.000313	0.000502	CcSEcCtD
Fentanyl—Body temperature increased—Galantamine—Alzheimer's disease	0.000313	0.000501	CcSEcCtD
Fentanyl—Abdominal pain—Galantamine—Alzheimer's disease	0.000313	0.000501	CcSEcCtD
Fentanyl—Tremor—Rivastigmine—Alzheimer's disease	0.000313	0.000501	CcSEcCtD
Fentanyl—ABCB1—brain—Alzheimer's disease	0.000312	0.00635	CbGeAlD
Fentanyl—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00031	0.000496	CcSEcCtD
Fentanyl—Confusional state—Donepezil—Alzheimer's disease	0.000309	0.000496	CcSEcCtD
Fentanyl—Anaemia—Rivastigmine—Alzheimer's disease	0.000308	0.000495	CcSEcCtD
Fentanyl—Malaise—Memantine—Alzheimer's disease	0.000308	0.000493	CcSEcCtD
Fentanyl—Agitation—Rivastigmine—Alzheimer's disease	0.000307	0.000492	CcSEcCtD
Fentanyl—Oedema—Donepezil—Alzheimer's disease	0.000307	0.000492	CcSEcCtD
Fentanyl—Vertigo—Memantine—Alzheimer's disease	0.000306	0.000491	CcSEcCtD
Fentanyl—Syncope—Memantine—Alzheimer's disease	0.000306	0.000491	CcSEcCtD
Fentanyl—Leukopenia—Memantine—Alzheimer's disease	0.000305	0.00049	CcSEcCtD
Fentanyl—Infection—Donepezil—Alzheimer's disease	0.000305	0.000488	CcSEcCtD
Fentanyl—Shock—Donepezil—Alzheimer's disease	0.000302	0.000484	CcSEcCtD
Fentanyl—Palpitations—Memantine—Alzheimer's disease	0.000301	0.000483	CcSEcCtD
Fentanyl—Malaise—Rivastigmine—Alzheimer's disease	0.000301	0.000483	CcSEcCtD
Fentanyl—Nervous system disorder—Donepezil—Alzheimer's disease	0.000301	0.000482	CcSEcCtD
Fentanyl—Thrombocytopenia—Donepezil—Alzheimer's disease	0.0003	0.000481	CcSEcCtD
Fentanyl—Vertigo—Rivastigmine—Alzheimer's disease	0.0003	0.000481	CcSEcCtD
Fentanyl—Loss of consciousness—Memantine—Alzheimer's disease	0.0003	0.000481	CcSEcCtD
Fentanyl—Syncope—Rivastigmine—Alzheimer's disease	0.000299	0.00048	CcSEcCtD
Fentanyl—Darifenacin—CYP2D6—Alzheimer's disease	0.000298	0.0263	CrCbGaD
Fentanyl—Cough—Memantine—Alzheimer's disease	0.000298	0.000477	CcSEcCtD
Fentanyl—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000296	0.000475	CcSEcCtD
Fentanyl—Convulsion—Memantine—Alzheimer's disease	0.000296	0.000474	CcSEcCtD
Fentanyl—Palpitations—Rivastigmine—Alzheimer's disease	0.000295	0.000473	CcSEcCtD
Fentanyl—Hypertension—Memantine—Alzheimer's disease	0.000294	0.000472	CcSEcCtD
Fentanyl—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000293	0.00047	CcSEcCtD
Fentanyl—Anorexia—Donepezil—Alzheimer's disease	0.000292	0.000469	CcSEcCtD
Fentanyl—Hypersensitivity—Galantamine—Alzheimer's disease	0.000291	0.000467	CcSEcCtD
Fentanyl—Cough—Rivastigmine—Alzheimer's disease	0.000291	0.000467	CcSEcCtD
Fentanyl—Arthralgia—Memantine—Alzheimer's disease	0.00029	0.000466	CcSEcCtD
Fentanyl—Myalgia—Memantine—Alzheimer's disease	0.00029	0.000466	CcSEcCtD
Fentanyl—Chest pain—Memantine—Alzheimer's disease	0.00029	0.000466	CcSEcCtD
Fentanyl—Fexofenadine—CYP2D6—Alzheimer's disease	0.00029	0.0256	CrCbGaD
Fentanyl—Anxiety—Memantine—Alzheimer's disease	0.000289	0.000464	CcSEcCtD
Fentanyl—Convulsion—Rivastigmine—Alzheimer's disease	0.000289	0.000464	CcSEcCtD
Fentanyl—Hypertension—Rivastigmine—Alzheimer's disease	0.000288	0.000462	CcSEcCtD
Fentanyl—Discomfort—Memantine—Alzheimer's disease	0.000287	0.00046	CcSEcCtD
Fentanyl—Hypotension—Donepezil—Alzheimer's disease	0.000286	0.000459	CcSEcCtD
Fentanyl—Myalgia—Rivastigmine—Alzheimer's disease	0.000284	0.000456	CcSEcCtD
Fentanyl—Arthralgia—Rivastigmine—Alzheimer's disease	0.000284	0.000456	CcSEcCtD
Fentanyl—Chest pain—Rivastigmine—Alzheimer's disease	0.000284	0.000456	CcSEcCtD
Fentanyl—Dry mouth—Memantine—Alzheimer's disease	0.000284	0.000455	CcSEcCtD
Fentanyl—Asthenia—Galantamine—Alzheimer's disease	0.000284	0.000455	CcSEcCtD
Fentanyl—Anxiety—Rivastigmine—Alzheimer's disease	0.000283	0.000454	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000282	0.000452	CcSEcCtD
Fentanyl—Confusional state—Memantine—Alzheimer's disease	0.000281	0.00045	CcSEcCtD
Fentanyl—Discomfort—Rivastigmine—Alzheimer's disease	0.000281	0.00045	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000279	0.000448	CcSEcCtD
Fentanyl—Oedema—Memantine—Alzheimer's disease	0.000278	0.000446	CcSEcCtD
Fentanyl—Dry mouth—Rivastigmine—Alzheimer's disease	0.000278	0.000446	CcSEcCtD
Fentanyl—Insomnia—Donepezil—Alzheimer's disease	0.000277	0.000445	CcSEcCtD
Fentanyl—Infection—Memantine—Alzheimer's disease	0.000277	0.000443	CcSEcCtD
Fentanyl—Paraesthesia—Donepezil—Alzheimer's disease	0.000275	0.000441	CcSEcCtD
Fentanyl—Confusional state—Rivastigmine—Alzheimer's disease	0.000275	0.00044	CcSEcCtD
Fentanyl—Shock—Memantine—Alzheimer's disease	0.000274	0.000439	CcSEcCtD
Fentanyl—Dyspnoea—Donepezil—Alzheimer's disease	0.000273	0.000438	CcSEcCtD
Fentanyl—Nervous system disorder—Memantine—Alzheimer's disease	0.000273	0.000438	CcSEcCtD
Fentanyl—Somnolence—Donepezil—Alzheimer's disease	0.000273	0.000437	CcSEcCtD
Fentanyl—Thrombocytopenia—Memantine—Alzheimer's disease	0.000273	0.000437	CcSEcCtD
Fentanyl—Oedema—Rivastigmine—Alzheimer's disease	0.000272	0.000437	CcSEcCtD
Fentanyl—Tachycardia—Memantine—Alzheimer's disease	0.000272	0.000436	CcSEcCtD
Fentanyl—Diarrhoea—Galantamine—Alzheimer's disease	0.000271	0.000434	CcSEcCtD
Fentanyl—Infection—Rivastigmine—Alzheimer's disease	0.000271	0.000434	CcSEcCtD
Fentanyl—Skin disorder—Memantine—Alzheimer's disease	0.00027	0.000434	CcSEcCtD
Fentanyl—Dyspepsia—Donepezil—Alzheimer's disease	0.00027	0.000433	CcSEcCtD
Fentanyl—Hyperhidrosis—Memantine—Alzheimer's disease	0.000269	0.000432	CcSEcCtD
Fentanyl—Shock—Rivastigmine—Alzheimer's disease	0.000268	0.00043	CcSEcCtD
Fentanyl—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000267	0.000428	CcSEcCtD
Fentanyl—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000267	0.000428	CcSEcCtD
Fentanyl—Decreased appetite—Donepezil—Alzheimer's disease	0.000267	0.000427	CcSEcCtD
Fentanyl—Tachycardia—Rivastigmine—Alzheimer's disease	0.000266	0.000426	CcSEcCtD
Fentanyl—Anorexia—Memantine—Alzheimer's disease	0.000265	0.000426	CcSEcCtD
Fentanyl—Benzatropine—CYP2D6—Alzheimer's disease	0.000265	0.0234	CrCbGaD
Fentanyl—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000265	0.000424	CcSEcCtD
Fentanyl—Skin disorder—Rivastigmine—Alzheimer's disease	0.000265	0.000424	CcSEcCtD
Fentanyl—Fatigue—Donepezil—Alzheimer's disease	0.000264	0.000424	CcSEcCtD
Fentanyl—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000263	0.000422	CcSEcCtD
Fentanyl—Constipation—Donepezil—Alzheimer's disease	0.000262	0.00042	CcSEcCtD
Fentanyl—Pain—Donepezil—Alzheimer's disease	0.000262	0.00042	CcSEcCtD
Fentanyl—Dizziness—Galantamine—Alzheimer's disease	0.000262	0.00042	CcSEcCtD
Fentanyl—Hypotension—Memantine—Alzheimer's disease	0.00026	0.000417	CcSEcCtD
Fentanyl—Anorexia—Rivastigmine—Alzheimer's disease	0.00026	0.000416	CcSEcCtD
Fentanyl—Hypotension—Rivastigmine—Alzheimer's disease	0.000254	0.000408	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000254	0.000407	CcSEcCtD
Fentanyl—Feeling abnormal—Donepezil—Alzheimer's disease	0.000253	0.000405	CcSEcCtD
Fentanyl—Insomnia—Memantine—Alzheimer's disease	0.000252	0.000404	CcSEcCtD
Fentanyl—Vomiting—Galantamine—Alzheimer's disease	0.000252	0.000403	CcSEcCtD
Fentanyl—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000251	0.000402	CcSEcCtD
Fentanyl—Paraesthesia—Memantine—Alzheimer's disease	0.00025	0.000401	CcSEcCtD
Fentanyl—Rash—Galantamine—Alzheimer's disease	0.000249	0.0004	CcSEcCtD
Fentanyl—Dermatitis—Galantamine—Alzheimer's disease	0.000249	0.0004	CcSEcCtD
Fentanyl—Dyspnoea—Memantine—Alzheimer's disease	0.000248	0.000398	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000248	0.000398	CcSEcCtD
Fentanyl—Headache—Galantamine—Alzheimer's disease	0.000248	0.000397	CcSEcCtD
Fentanyl—Somnolence—Memantine—Alzheimer's disease	0.000247	0.000397	CcSEcCtD
Fentanyl—Insomnia—Rivastigmine—Alzheimer's disease	0.000246	0.000395	CcSEcCtD
Fentanyl—Dyspepsia—Memantine—Alzheimer's disease	0.000245	0.000393	CcSEcCtD
Fentanyl—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000245	0.000392	CcSEcCtD
Fentanyl—Urticaria—Donepezil—Alzheimer's disease	0.000244	0.000391	CcSEcCtD
Fentanyl—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000243	0.000389	CcSEcCtD
Fentanyl—Abdominal pain—Donepezil—Alzheimer's disease	0.000242	0.000389	CcSEcCtD
Fentanyl—Body temperature increased—Donepezil—Alzheimer's disease	0.000242	0.000389	CcSEcCtD
Fentanyl—Somnolence—Rivastigmine—Alzheimer's disease	0.000242	0.000388	CcSEcCtD
Fentanyl—Decreased appetite—Memantine—Alzheimer's disease	0.000242	0.000388	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00024	0.000385	CcSEcCtD
Fentanyl—Fatigue—Memantine—Alzheimer's disease	0.00024	0.000385	CcSEcCtD
Fentanyl—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00024	0.000384	CcSEcCtD
Fentanyl—Pain—Memantine—Alzheimer's disease	0.000238	0.000382	CcSEcCtD
Fentanyl—Constipation—Memantine—Alzheimer's disease	0.000238	0.000382	CcSEcCtD
Fentanyl—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000237	0.00038	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000235	0.000377	CcSEcCtD
Fentanyl—Nausea—Galantamine—Alzheimer's disease	0.000235	0.000377	CcSEcCtD
Fentanyl—Fatigue—Rivastigmine—Alzheimer's disease	0.000235	0.000377	CcSEcCtD
Fentanyl—Propafenone—CYP2D6—Alzheimer's disease	0.000234	0.0206	CrCbGaD
Fentanyl—Pain—Rivastigmine—Alzheimer's disease	0.000233	0.000373	CcSEcCtD
Fentanyl—Constipation—Rivastigmine—Alzheimer's disease	0.000233	0.000373	CcSEcCtD
Fentanyl—Feeling abnormal—Memantine—Alzheimer's disease	0.000229	0.000368	CcSEcCtD
Fentanyl—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000228	0.000365	CcSEcCtD
Fentanyl—Hypersensitivity—Donepezil—Alzheimer's disease	0.000226	0.000362	CcSEcCtD
Fentanyl—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000224	0.00036	CcSEcCtD
Fentanyl—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000223	0.000357	CcSEcCtD
Fentanyl—Urticaria—Memantine—Alzheimer's disease	0.000221	0.000355	CcSEcCtD
Fentanyl—Abdominal pain—Memantine—Alzheimer's disease	0.00022	0.000353	CcSEcCtD
Fentanyl—Body temperature increased—Memantine—Alzheimer's disease	0.00022	0.000353	CcSEcCtD
Fentanyl—Asthenia—Donepezil—Alzheimer's disease	0.00022	0.000353	CcSEcCtD
Fentanyl—Pruritus—Donepezil—Alzheimer's disease	0.000217	0.000348	CcSEcCtD
Fentanyl—Urticaria—Rivastigmine—Alzheimer's disease	0.000216	0.000347	CcSEcCtD
Fentanyl—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000215	0.000345	CcSEcCtD
Fentanyl—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000215	0.000345	CcSEcCtD
Fentanyl—Phenylbutazone—PTGS2—Alzheimer's disease	0.00021	0.0185	CrCbGaD
Fentanyl—Diarrhoea—Donepezil—Alzheimer's disease	0.00021	0.000336	CcSEcCtD
Fentanyl—Bepridil—CYP2D6—Alzheimer's disease	0.000208	0.0184	CrCbGaD
Fentanyl—Hypersensitivity—Memantine—Alzheimer's disease	0.000205	0.000329	CcSEcCtD
Fentanyl—Dizziness—Donepezil—Alzheimer's disease	0.000203	0.000325	CcSEcCtD
Fentanyl—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000201	0.000322	CcSEcCtD
Fentanyl—Diphenhydramine—PTGS1—Alzheimer's disease	0.0002	0.0176	CrCbGaD
Fentanyl—Asthenia—Memantine—Alzheimer's disease	0.0002	0.00032	CcSEcCtD
Fentanyl—Pruritus—Memantine—Alzheimer's disease	0.000197	0.000316	CcSEcCtD
Fentanyl—Asthenia—Rivastigmine—Alzheimer's disease	0.000195	0.000313	CcSEcCtD
Fentanyl—Vomiting—Donepezil—Alzheimer's disease	0.000195	0.000313	CcSEcCtD
Fentanyl—Dextropropoxyphene—CYP2D6—Alzheimer's disease	0.000194	0.0171	CrCbGaD
Fentanyl—Rash—Donepezil—Alzheimer's disease	0.000193	0.00031	CcSEcCtD
Fentanyl—Dermatitis—Donepezil—Alzheimer's disease	0.000193	0.00031	CcSEcCtD
Fentanyl—Pruritus—Rivastigmine—Alzheimer's disease	0.000193	0.000309	CcSEcCtD
Fentanyl—Headache—Donepezil—Alzheimer's disease	0.000192	0.000308	CcSEcCtD
Fentanyl—Diarrhoea—Memantine—Alzheimer's disease	0.00019	0.000305	CcSEcCtD
Fentanyl—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000186	0.000299	CcSEcCtD
Fentanyl—Loperamide—CYP2D6—Alzheimer's disease	0.000185	0.0163	CrCbGaD
Fentanyl—Dizziness—Memantine—Alzheimer's disease	0.000184	0.000295	CcSEcCtD
Fentanyl—Nausea—Donepezil—Alzheimer's disease	0.000182	0.000292	CcSEcCtD
Fentanyl—Dizziness—Rivastigmine—Alzheimer's disease	0.00018	0.000289	CcSEcCtD
Fentanyl—Vomiting—Memantine—Alzheimer's disease	0.000177	0.000284	CcSEcCtD
Fentanyl—Rash—Memantine—Alzheimer's disease	0.000176	0.000281	CcSEcCtD
Fentanyl—Dermatitis—Memantine—Alzheimer's disease	0.000175	0.000281	CcSEcCtD
Fentanyl—Headache—Memantine—Alzheimer's disease	0.000174	0.00028	CcSEcCtD
Fentanyl—Vomiting—Rivastigmine—Alzheimer's disease	0.000173	0.000278	CcSEcCtD
Fentanyl—Rash—Rivastigmine—Alzheimer's disease	0.000172	0.000275	CcSEcCtD
Fentanyl—Dermatitis—Rivastigmine—Alzheimer's disease	0.000172	0.000275	CcSEcCtD
Fentanyl—Headache—Rivastigmine—Alzheimer's disease	0.000171	0.000274	CcSEcCtD
Fentanyl—Nausea—Memantine—Alzheimer's disease	0.000165	0.000265	CcSEcCtD
Fentanyl—Nausea—Rivastigmine—Alzheimer's disease	0.000162	0.000259	CcSEcCtD
Fentanyl—Diphenhydramine—CYP2D6—Alzheimer's disease	0.000136	0.012	CrCbGaD
Fentanyl—Methadone—CYP2D6—Alzheimer's disease	0.000131	0.0116	CrCbGaD
Fentanyl—OPRK1—GPCR downstream signaling—F2—Alzheimer's disease	3.69e-05	0.000469	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PTK2B—Alzheimer's disease	3.68e-05	0.000467	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	3.66e-05	0.000466	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CCR5—Alzheimer's disease	3.63e-05	0.000462	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	3.63e-05	0.000462	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GAB2—Alzheimer's disease	3.58e-05	0.000455	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SST—Alzheimer's disease	3.58e-05	0.000455	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NTRK2—Alzheimer's disease	3.58e-05	0.000455	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CALM1—Alzheimer's disease	3.56e-05	0.000453	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—HTR2A—Alzheimer's disease	3.55e-05	0.000452	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GSK3A—Alzheimer's disease	3.54e-05	0.000451	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NGFR—Alzheimer's disease	3.5e-05	0.000445	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—APP—Alzheimer's disease	3.48e-05	0.000443	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PRKCG—Alzheimer's disease	3.48e-05	0.000442	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ACHE—Alzheimer's disease	3.48e-05	0.000442	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CREB1—Alzheimer's disease	3.48e-05	0.000442	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NPY—Alzheimer's disease	3.46e-05	0.000441	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IAPP—Alzheimer's disease	3.44e-05	0.000438	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—INPP5D—Alzheimer's disease	3.44e-05	0.000437	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ADAM10—Alzheimer's disease	3.42e-05	0.000435	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CCL2—Alzheimer's disease	3.4e-05	0.000433	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	3.4e-05	0.000432	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—F2—Alzheimer's disease	3.35e-05	0.000426	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CRH—Alzheimer's disease	3.34e-05	0.000425	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CCR5—Alzheimer's disease	3.3e-05	0.000419	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PLCB1—Alzheimer's disease	3.29e-05	0.000418	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS1—Alzheimer's disease	3.26e-05	0.000414	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ENO1—Alzheimer's disease	3.26e-05	0.000414	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CHAT—Alzheimer's disease	3.24e-05	0.000412	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—TPI1—Alzheimer's disease	3.24e-05	0.000412	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—S100B—Alzheimer's disease	3.23e-05	0.000411	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HTR2A—Alzheimer's disease	3.23e-05	0.00041	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYP2D6—Alzheimer's disease	3.2e-05	0.000406	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NPS—Alzheimer's disease	3.17e-05	0.000403	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PPP3CA—Alzheimer's disease	3.15e-05	0.000401	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	3.12e-05	0.000397	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—F2—Alzheimer's disease	3.11e-05	0.000396	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—MAOB—Alzheimer's disease	3.11e-05	0.000395	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PTK2B—Alzheimer's disease	3.11e-05	0.000395	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CA4—Alzheimer's disease	3.09e-05	0.000392	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IGF2—Alzheimer's disease	3.08e-05	0.000391	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NGFR—Alzheimer's disease	3.07e-05	0.00039	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CREB1—Alzheimer's disease	3.05e-05	0.000388	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—BCHE—Alzheimer's disease	3.03e-05	0.000385	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GAB2—Alzheimer's disease	3.02e-05	0.000384	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SST—Alzheimer's disease	3.02e-05	0.000384	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NTRK2—Alzheimer's disease	3.02e-05	0.000384	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CALM1—Alzheimer's disease	3.01e-05	0.000383	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ADAM10—Alzheimer's disease	3e-05	0.000381	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GSK3A—Alzheimer's disease	3e-05	0.000381	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GAPDH—Alzheimer's disease	2.99e-05	0.00038	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CCL2—Alzheimer's disease	2.98e-05	0.000379	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IGF1R—Alzheimer's disease	2.97e-05	0.000378	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APP—Alzheimer's disease	2.94e-05	0.000375	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.9e-05	0.000369	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—A2M—Alzheimer's disease	2.89e-05	0.000367	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.88e-05	0.000367	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PLCB1—Alzheimer's disease	2.86e-05	0.000364	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—LPL—Alzheimer's disease	2.85e-05	0.000363	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—S100B—Alzheimer's disease	2.83e-05	0.00036	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—F2—Alzheimer's disease	2.83e-05	0.00036	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MEF2C—Alzheimer's disease	2.83e-05	0.000359	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PLCB1—Alzheimer's disease	2.78e-05	0.000353	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PRKCG—Alzheimer's disease	2.77e-05	0.000353	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ABCA1—Alzheimer's disease	2.77e-05	0.000352	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	2.77e-05	0.000352	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.75e-05	0.00035	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NGF—Alzheimer's disease	2.7e-05	0.000344	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF2—Alzheimer's disease	2.7e-05	0.000343	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	2.65e-05	0.000337	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCR5—Alzheimer's disease	2.63e-05	0.000334	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PLD3—Alzheimer's disease	2.62e-05	0.000334	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF1R—Alzheimer's disease	2.61e-05	0.000332	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NGFR—Alzheimer's disease	2.59e-05	0.00033	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CREB1—Alzheimer's disease	2.58e-05	0.000328	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HTR2A—Alzheimer's disease	2.57e-05	0.000327	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ADAM10—Alzheimer's disease	2.53e-05	0.000322	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CCL2—Alzheimer's disease	2.52e-05	0.000321	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	2.52e-05	0.00032	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ACHE—Alzheimer's disease	2.51e-05	0.00032	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—LPL—Alzheimer's disease	2.5e-05	0.000318	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	2.48e-05	0.000316	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MEF2C—Alzheimer's disease	2.48e-05	0.000315	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.47e-05	0.000314	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—TPI1—Alzheimer's disease	2.45e-05	0.000311	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CHAT—Alzheimer's disease	2.45e-05	0.000311	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PRKCG—Alzheimer's disease	2.43e-05	0.000309	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	2.42e-05	0.000308	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CALM1—Alzheimer's disease	2.4e-05	0.000305	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—S100B—Alzheimer's disease	2.39e-05	0.000305	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—APOE—Alzheimer's disease	2.39e-05	0.000304	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—LEP—Alzheimer's disease	2.39e-05	0.000304	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PPARGC1A—Alzheimer's disease	2.39e-05	0.000304	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—HMOX1—Alzheimer's disease	2.38e-05	0.000302	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CAV1—Alzheimer's disease	2.37e-05	0.000301	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NGF—Alzheimer's disease	2.37e-05	0.000301	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	2.36e-05	0.0003	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ENO1—Alzheimer's disease	2.36e-05	0.0003	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—MAOB—Alzheimer's disease	2.35e-05	0.000298	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ND1—Alzheimer's disease	2.34e-05	0.000297	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	2.31e-05	0.000294	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCR5—Alzheimer's disease	2.3e-05	0.000293	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ESR1—Alzheimer's disease	2.28e-05	0.00029	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF2—Alzheimer's disease	2.28e-05	0.00029	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GAPDH—Alzheimer's disease	2.26e-05	0.000287	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HTR2A—Alzheimer's disease	2.25e-05	0.000287	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—F2—Alzheimer's disease	2.25e-05	0.000287	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NOTCH1—Alzheimer's disease	2.21e-05	0.000281	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF1R—Alzheimer's disease	2.2e-05	0.00028	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—BCHE—Alzheimer's disease	2.19e-05	0.000278	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—A2M—Alzheimer's disease	2.18e-05	0.000277	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.18e-05	0.000277	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—LPL—Alzheimer's disease	2.17e-05	0.000276	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—LPL—Alzheimer's disease	2.11e-05	0.000269	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CALM1—Alzheimer's disease	2.1e-05	0.000268	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—APOE—Alzheimer's disease	2.1e-05	0.000267	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—LEP—Alzheimer's disease	2.1e-05	0.000267	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MEF2C—Alzheimer's disease	2.09e-05	0.000266	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CAV1—Alzheimer's disease	2.08e-05	0.000264	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—GSK3B—Alzheimer's disease	2.07e-05	0.000263	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	2.07e-05	0.000263	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PRKCG—Alzheimer's disease	2.06e-05	0.000261	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CREB1—Alzheimer's disease	2.05e-05	0.000261	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—INS—Alzheimer's disease	2.04e-05	0.00026	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCL2—Alzheimer's disease	2.01e-05	0.000256	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	2e-05	0.000255	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NGF—Alzheimer's disease	2e-05	0.000255	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ESR1—Alzheimer's disease	2e-05	0.000255	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—F2—Alzheimer's disease	1.98e-05	0.000251	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IGF1—Alzheimer's disease	1.98e-05	0.000251	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—MTHFR—Alzheimer's disease	1.96e-05	0.000249	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCR5—Alzheimer's disease	1.95e-05	0.000248	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.93e-05	0.000246	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HTR2A—Alzheimer's disease	1.91e-05	0.000242	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ACHE—Alzheimer's disease	1.9e-05	0.000241	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—INPP5D—Alzheimer's disease	1.87e-05	0.000238	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.84e-05	0.000234	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CALM1—Alzheimer's disease	1.83e-05	0.000233	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—APOE—Alzheimer's disease	1.82e-05	0.000232	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—GSK3B—Alzheimer's disease	1.82e-05	0.000231	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CAV1—Alzheimer's disease	1.81e-05	0.00023	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CREB1—Alzheimer's disease	1.8e-05	0.000229	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NOS3—Alzheimer's disease	1.79e-05	0.000228	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—INS—Alzheimer's disease	1.79e-05	0.000228	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CALM1—Alzheimer's disease	1.78e-05	0.000226	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS1—Alzheimer's disease	1.78e-05	0.000226	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ENO1—Alzheimer's disease	1.78e-05	0.000226	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—LEP—Alzheimer's disease	1.77e-05	0.000225	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APOE—Alzheimer's disease	1.77e-05	0.000225	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCL2—Alzheimer's disease	1.76e-05	0.000224	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CAV1—Alzheimer's disease	1.76e-05	0.000223	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	1.74e-05	0.000222	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF1—Alzheimer's disease	1.73e-05	0.00022	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	1.73e-05	0.00022	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	1.72e-05	0.000219	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ESR1—Alzheimer's disease	1.69e-05	0.000215	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—F2—Alzheimer's disease	1.67e-05	0.000212	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—BCHE—Alzheimer's disease	1.65e-05	0.00021	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.63e-05	0.000208	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PPARG—Alzheimer's disease	1.59e-05	0.000202	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—LPL—Alzheimer's disease	1.57e-05	0.0002	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOS3—Alzheimer's disease	1.57e-05	0.0002	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PLCB1—Alzheimer's disease	1.56e-05	0.000198	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—INS—Alzheimer's disease	1.56e-05	0.000198	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.53e-05	0.000195	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—GSK3B—Alzheimer's disease	1.53e-05	0.000195	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CREB1—Alzheimer's disease	1.52e-05	0.000194	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CASP3—Alzheimer's disease	1.52e-05	0.000193	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—INS—Alzheimer's disease	1.51e-05	0.000192	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ABCA1—Alzheimer's disease	1.51e-05	0.000192	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL6—Alzheimer's disease	1.51e-05	0.000192	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.51e-05	0.000192	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.51e-05	0.000192	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCL2—Alzheimer's disease	1.49e-05	0.000189	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF1—Alzheimer's disease	1.46e-05	0.000186	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.44e-05	0.000184	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	1.41e-05	0.00018	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MAPK8—Alzheimer's disease	1.4e-05	0.000178	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—AKT1—Alzheimer's disease	1.39e-05	0.000177	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.39e-05	0.000177	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—NOS3—Alzheimer's disease	1.37e-05	0.000174	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.35e-05	0.000171	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.34e-05	0.000171	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CASP3—Alzheimer's disease	1.33e-05	0.00017	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOS3—Alzheimer's disease	1.33e-05	0.000169	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL6—Alzheimer's disease	1.32e-05	0.000168	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CALM1—Alzheimer's disease	1.32e-05	0.000168	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—APOE—Alzheimer's disease	1.32e-05	0.000168	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CAV1—Alzheimer's disease	1.31e-05	0.000166	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	1.3e-05	0.000166	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HMOX1—Alzheimer's disease	1.3e-05	0.000165	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—VEGFA—Alzheimer's disease	1.29e-05	0.000164	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	1.25e-05	0.000159	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MAPK8—Alzheimer's disease	1.23e-05	0.000156	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—AKT1—Alzheimer's disease	1.22e-05	0.000155	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—LPL—Alzheimer's disease	1.19e-05	0.000151	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TGFB1—Alzheimer's disease	1.18e-05	0.000151	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.17e-05	0.000149	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.16e-05	0.000147	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARG—Alzheimer's disease	1.15e-05	0.000146	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.14e-05	0.000145	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—VEGFA—Alzheimer's disease	1.13e-05	0.000144	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CASP3—Alzheimer's disease	1.13e-05	0.000143	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—INS—Alzheimer's disease	1.13e-05	0.000143	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.12e-05	0.000142	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.09e-05	0.000139	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.09e-05	0.000139	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.07e-05	0.000137	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.07e-05	0.000136	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TGFB1—Alzheimer's disease	1.04e-05	0.000132	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.04e-05	0.000132	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.03e-05	0.000131	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.02e-05	0.000129	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CALM1—Alzheimer's disease	9.97e-06	0.000127	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOE—Alzheimer's disease	9.94e-06	0.000126	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—NOS3—Alzheimer's disease	9.87e-06	0.000126	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CAV1—Alzheimer's disease	9.85e-06	0.000125	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TP53—Alzheimer's disease	9.75e-06	0.000124	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	9.61e-06	0.000122	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—VEGFA—Alzheimer's disease	9.56e-06	0.000122	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	9.31e-06	0.000118	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	9.03e-06	0.000115	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL6—Alzheimer's disease	8.92e-06	0.000114	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TGFB1—Alzheimer's disease	8.78e-06	0.000112	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARG—Alzheimer's disease	8.66e-06	0.00011	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TP53—Alzheimer's disease	8.55e-06	0.000109	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—INS—Alzheimer's disease	8.49e-06	0.000108	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—AKT1—Alzheimer's disease	8.23e-06	0.000105	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	8.02e-06	0.000102	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	7.99e-06	0.000102	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6—Alzheimer's disease	7.83e-06	9.95e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NOS3—Alzheimer's disease	7.45e-06	9.47e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LPL—Alzheimer's disease	7.31e-06	9.29e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TP53—Alzheimer's disease	7.23e-06	9.19e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKT1—Alzheimer's disease	7.22e-06	9.18e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS2—Alzheimer's disease	6.81e-06	8.66e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6—Alzheimer's disease	6.61e-06	8.41e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	6.58e-06	8.37e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—AKT1—Alzheimer's disease	6.28e-06	7.98e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CALM1—Alzheimer's disease	6.15e-06	7.82e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOE—Alzheimer's disease	6.12e-06	7.79e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKT1—Alzheimer's disease	6.1e-06	7.76e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CAV1—Alzheimer's disease	6.07e-06	7.72e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARG—Alzheimer's disease	5.33e-06	6.78e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—INS—Alzheimer's disease	5.23e-06	6.65e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NOS3—Alzheimer's disease	4.59e-06	5.84e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—AKT1—Alzheimer's disease	4.54e-06	5.77e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	4.2e-06	5.34e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AKT1—Alzheimer's disease	3.42e-06	4.35e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AKT1—Alzheimer's disease	2.11e-06	2.68e-05	CbGpPWpGaD
